A differential of >100 was defined as a cut-off for PDL-1 exosomal levels between pre- and post-CPI treatment (bearing 83% sensitivity, 70% specificity, a 91% positive predictive value and a 54% negative predictive value), as meaningful in relation to tumor progression (Nardin et al., 2019). This evidence concerns the gene CD274 and neoplasm.